Contact this trialFirst, we need to learn more about you.
Procedure
Metastasis and Primary Directed Therapy for Kidney Cancer
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial aims to see how well patients with kidney cancer respond to a new treatment approach after initial therapy. Researchers believe that patients who receive this new treatment followed by stopping systemic therapy will have a better survival
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service